Scholar Rock gets FDA nod for spinal muscular atrophy drug

Scholar Rock has won FDA approval for its drug treating a rare muscle-wasting disease, after facing delays due to a troubled manufacturing factory. The injectable drug apitegromab, branded as Isembyld, was